The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs / Inspections and Audits

Indian Hospira Plant Gets Extensive Form 483

Jan. 24, 2014
Sterile injectables maker Hospira was hit with a new Form 483 containing nearly two dozen observations after FDA investigators followed up an October 2012 inspection that uncovered inadequate sanitization procedures at its Irungattukottai, India, facility.
Drug GMP Report